55513-750 : Repatha 140 mg/ml Subcutaneous Injection, Solution


NDC: 55513-750
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Repatha
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125522
Rev. Date: 


NDC Package Codes:

  • 55513-750-01: 1 SYRINGE IN 1 CARTON (55513‑750‑01) > 1 ML IN 1 SYRINGE

Active Ingredients:

  • Evolocumab

Dosage Strength:

  • 140 mg/mL

Pharmaceutical Classes:

  • Antibodies
  • Monoclonal [CS]
  • PCSK9 Inhibitor [EPC]
  • PCSK9 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 55513-760 Repatha 140 mg/ml Subcutaneous Injection, Solution by Amgen Inc
  • 55513-770 Repatha Kit by Amgen Inc
  • 72511-750 Repatha 140 mg/ml Subcutaneous Injection, Solution by Amgen USA Inc.
  • 72511-760 Repatha 140 mg/ml Subcutaneous Injection, Solution by Amgen USA Inc.
  • 72511-770 Repatha Subcutaneous Kit by Amgen USA Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-750 QR Code

< Prev: 55513-742Next: 55513-760 >

Related Discussions:

Repatha side effects
What side effects have been experienced with this drug? I have been advised to take Repatha. Since I am sensitive, and h... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.